TABLE 3.
HIV-infected individualsa
| Subject no. | Gender | Age (in yrs) | Sample moment (no. of yrs after SC) | No. of CD4 cells/μl | No. of CD8 cells/μl | HIV viral load (copies/ml plasma) | cART (no. of yrs after SC) | AIDS | AIDS diagnosis (no. of yrs after SC) | EBV serostatus | hCMV serostatus |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Male | 41 | 3 | 380 | 690 | 32,000 | No | Yes | 5 | ND | + |
| 2 | Male | 51 | 3 | 590 | 590 | 1,000 | No | Yes | 9 | ND | + |
| 3 | Male | 31 | 3 | 710 | 860 | 6,700 | Yes (14) | No | ND | + | |
| 4 | Male | 31 | 3 | 270 | 710 | 360,000 | No | Yes | 6 | ND | + |
| 5 | Male | 38 | 4 | 1,140 | 1,000 | 1,300 | No | No | ND | + | |
| 6 | Male | 44 | 4 | 950 | 790 | 1,000 | Yes (14) | No | ND | + | |
| 7 | Male | 36 | 4 | 1,220 | 910 | 1,000 | No | Yes | 7 | ND | + |
| 8 | Male | 37 | 4 | 460 | 440 | 24,000 | No | Yes | 12 | ND | − |
| 9 | Male | 43 | 4 | 770 | 1,910 | 1,000 | No | Yes | 8 | ND | + |
| 10 | Male | 40 | 4 | 400 | 680 | 1,700 | Yes (15) | Yes | 8 | ND | + |
| 11 | Male | 39 | 4 | 920 | 680 | 1,000 | Yes (15) | Yes | 6 | ND | + |
| 12 | Male | 38 | 4 | 290 | 850 | 13,000 | No | Yes | 5 | ND | + |
| 13 | Male | 30 | 4 | 1,060 | 1,270 | 1,000 | No | Yes | 9 | ND | − |
SC, seroconversion; ND, not determined; cART, combination antiretroviral therapy; +, positive; −, negative.